Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C63 - Cutting-edge Concepts and Applications in Technology, Cellular Therapy, Imaging, and Interventions and Rehabilitation of Stroke

Monday 04/04/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Pierre Fayad, MD, FAAN, FAHA
Cerebrovascular Disease and Interventional Neurology
By the end of the course the participants will become familiar with the state-of-the art approach to the prevention, acute management and functional restoration of patients with stroke with a perspective on what is coming through the pipeline. Building on a brief summary update, participants will gain an overview of ongoing trials, remaining knowledge gaps and promising imaging, technological, and scientific advances that could potentially provide solutions to our knowledge gaps.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Introduction Overview of Session and Introduction of Speakers
Pierre Fayad, MD, FAAN, FAHA
07:00 AM - 07:00 AM PDT Speaker walk in slides
Pierre Fayad, MD, FAAN, FAHA
07:05 AM - 07:35 AM PDT Speaker Promising Advances in the Acute and Interventional Management of Stroke
Raul G. Nogueira, MD
07:35 AM - 08:05 AM PDT Speaker State-of-the-Art and Promising Advances in Stroke Recovery and Restoration
Wayne W. Feng, MD, FAAN
08:05 AM - 08:35 AM PDT Speaker State-of-the-Art and Promising Advances in Stroke Prevention
Pierre Fayad, MD, FAAN, FAHA
08:35 AM - 09:00 AM PDT Q&A Panel Discussion & Questions and Answers
Faculty Disclosures
Pierre Fayad, MD, FAAN, FAHA Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Wayne W. Feng, MD, FAAN Dr. Feng has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precision Neuroscience. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association .
Raul G. Nogueira, MD Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.